Fol. Biol. 2011, 57, 248-254
https://doi.org/10.14712/fb2011057060248
Hepcidin Expression in the Liver of Mice with Implanted Tumour Reacts to Iron Deficiency, Inflammation and Erythropoietin Administration
References
1. Adamson, J. W. (2008) The anemia of inflammation/malignancy: mechanisms and management. Hematology Am. Soc. Hematol. Educ. Program 159-165.
2. 2006) Hepcidin and multiple myeloma related anemia. Med. Hypotheses 66, 352-354.
< , A., Patiu, M., Rusu, A. (https://doi.org/10.1016/j.mehy.2005.08.041>
3. 2010) Anemia in cancer. Ann. Oncol. 21 (Suppl 7), vii167-vii172.
< , M., Plawny, L., Diederich, M. (https://doi.org/10.1093/annonc/mdq284>
4. 2009) Iron sequestration and anemia of inflammation. Semin. Hematol. 46, 387-393.
< , T., Nemeth, E. (https://doi.org/10.1053/j.seminhematol.2009.06.001>
5. 2008) Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med. Oncol. 25, 12-21.
< , H. Z. (https://doi.org/10.1007/s12032-007-9000-8>
6. 2010) Anemia in Hodgkin’s lymphoma: the role of interleukin-6 and hepcidin. J. Clin. Oncol. 28, 2538-2543.
< , S., Massini, G., Giachelia, M., Vannata, B., Bozzoli, V., Cuccaro, A., D’Alo, F., Larocca, L. M., Raymakers, R. A., Swinkels, D. W., Voso, M. T., Leone, G. (https://doi.org/10.1200/JCO.2009.27.6873>
7. 2009) Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 113, 3593-3599.
< , H., Constante, M., Layoun, A., Santos, M. M. (https://doi.org/10.1182/blood-2008-08-173641>
8. 2007) Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia. Med. Oncol. 24, 323-329.
< , M. L., Mamoni, R. L., Lima, C. S., Dos Anjos, B. L., Grotto, H. Z. (https://doi.org/10.1007/s12032-007-0009-9>
9. 2009) Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma. BMC Cancer 9, 270.
< , T., Tomosugi, N., Abe, H., Arai, K., Yoshida, K. (https://doi.org/10.1186/1471-2407-9-270>
10. 2009a) Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma. Cancer Treat. Rev. 35, 738-743.
< , E., Dimopoulos, M. A., Zervas, K., Terpos, E. (https://doi.org/10.1016/j.ctrv.2009.08.002>
11. 2009b) Sequential evaluation of serum hepcidin in anemic myeloma patients: study of correlations with myeloma treatment, disease variables, and anemia response. Am. J. Hematol. 84, 524-526.
< , E., Ganz, T., Terpos, E., Verrou, E., Olbina, G., Gastari, V., Hadjiaggelidou, C., Varthaliti, M., Georgiadou, S., Westerman, M., Zervas, K. (https://doi.org/10.1002/ajh.21448>
12. 2008) Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 112, 1503-1509.
< , L., Meynard, D., Monnier, A., Darnaud, V., Bouvet, R., Wang, R. H., Deng, C., Vaulont, S., Mosser, J., Coppin, H., Roth, M. P. (https://doi.org/10.1182/blood-2008-03-143354>
13. 2005) Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106, 1864-1866.
< , E. H., Pickkers, P., Nemeth, E., van der Hoeven, H., Swinkels, D. (https://doi.org/10.1182/blood-2005-03-1159>
14. 2008) Hepcidin: from discovery to differential diagnosis. Haematologica 93, 90-97.
< , E. H., Tjalsma, H., Willems, H. L., Swinkels, D. W. (https://doi.org/10.3324/haematol.11705>
15. 2008) Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma. BMC Cancer 8, 167.
< , H., Sawada, T., Tomosugi, N., Kubota, K. (https://doi.org/10.1186/1471-2407-8-167>
16. 2004) Different expression pattern of hepcidin genes in the liver and pancreas of C57BL/6N and DBA/2N mice. J. Hepatol. 40, 891-896.
< , J., Cmejla, R., Sykora, V., Vokurka, M., Vyoral, D., Necas. E. (https://doi.org/10.1016/j.jhep.2004.02.029>
17. 2004) Functional differences between hepcidin 1 and 2 in transgenic mice. Blood 103, 2816-2821.
< , D. Q., Nicolas, G., Lesbordes, J. C., Viatte, L., Grimber, G., Szajnert, M. F., Kahn, A., Vaulont, S. (https://doi.org/10.1182/blood-2003-07-2524>
18. 2003) Dietary iron regulates hepatic hepcidin 1 and 2 mRNAs in mice. Metabolism 52, 1229-1231.
< , A., Feillet-Coudray, C., Romier, B., Bayle, D., Gueux, E., Ruivard, M., Coudray, C., Rayssiguier, Y. (https://doi.org/10.1016/S0026-0495(03)00277-4>
19. 2004a) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113, 1271-1276.
< , E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., Ganz, T. (https://doi.org/10.1172/JCI200420945>
20. 2004b) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093.
< , E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., Kaplan, J. (https://doi.org/10.1126/science.1104742>
21. 2009) The role of hepcidin in iron metabolism. Acta Haematol. 122, 78-86.
< , E., Ganz, T. (https://doi.org/10.1159/000243791>
22. 2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98, 8780-8785.
< , G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., Vaulont, S. (https://doi.org/10.1073/pnas.151179498>
23. 2002a) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037-1044.
< , G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., Vaulont, S. (https://doi.org/10.1172/JCI0215686>
24. 2002b) Hepcidin, a new iron regulatory peptide. Blood Cells Mol. Dis. 29, 327-335.
< , G., Viatte, L., Bennoun, M., Beaumont, C., Kahn, A., Vaulont, S. (https://doi.org/10.1006/bcmd.2002.0573>
25. 2006) Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108, 3730-3735.
< , M., Lopez, M. A., Gabayan, V., Ganz, T., Rivera, S. (https://doi.org/10.1182/blood-2006-06-028787>
26. 2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276, 7811-7819.
< , C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., Loreal, O. (https://doi.org/10.1074/jbc.M008923200>
27. 1998) Antitumor action of bovine seminal ribonuclease. Cytostatic effect on human melanoma and mouse seminoma. Neoplasma 45, 30-34.
, P., Soucek, J., Jelinek, J., Zadinova, M., Hlouskova, D., Polivkova, J., Navratil, L., Cinatl, J., Matousek, J. (
28. 2010) Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Blood Cells Mol. Dis. 45, 238-245.
< , B. J., Li, H., Rose, M. J., Arvedson, T. L., Doellgast, G., Molineux, G. (https://doi.org/10.1016/j.bcmd.2010.07.013>
29. 2008) Involvement of hepcidin in the anemia of multiple myeloma. Clin. Cancer Res. 14, 3262-3267.
< , S., Nemeth, E., Chen, Y. H., Goodnough, J., Huston, A., Roodman, G. D., Ganz, T., Lichtenstein, A. (https://doi.org/10.1158/1078-0432.CCR-07-4153>
30. 2009) Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences. Exp. Biol. Med. (Maywood) 234, 693-702.
< , M. G., Kumarasinghe, M. P., Wang, S. M., Ooi, L. L., Aw, S. E., Hui, K. M. (https://doi.org/10.3181/0807-RM-227>
31. 2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med. 13, 1096-1101.
< , T., Bhanu, N. V., Oneal, P. A., Goh, S. H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R. H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., Miller, J. L. (https://doi.org/10.1038/nm1629>
32. 2009) Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114, 181-186.
< , T., Porayette, P., Sripichai, O., Noh, S. J., Byrnes, C., Bhupatiraju, A., Lee, Y. T., Goodnough, J. B., Harandi, O., Ganz, T., Paulson, R. F., Miller, J. L. (https://doi.org/10.1182/blood-2008-12-195503>
33. 2009) Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113, 5277-5286.
< , I., Aigner, E., Theurl, M., Nairz, M., Seifert, M., Schroll, A., Sonnweber, T., Eberwein, L., Witcher, D. R., Murphy, A. T., Wroblewski, V. J., Wurz, E., Datz, C., Weiss, G. (https://doi.org/10.1182/blood-2008-12-195651>
34. 1980) Tissue iron stores. Methods Hematol. 1, 90-115.
, J. D., Bothwell, T. H. (
35. 2009) Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications. J. Cancer Res. Clin. Oncol. 135, 1413-1420.
< , H. H., Chang, J. G., Hwang, Y. H., Yeh, K. T., Chen, Y. L., Yu, H. S. (https://doi.org/10.1007/s00432-009-0585-5>
36. 2009) Hepcidin as a predictor of response to epoetin therapy in anemic cancer patients. Clin. Chem. 55, 1354-1360.
< , L., Johannes, H., Beyer, U., Zaug, M., Osterwalder, B., Scherhag, A. (https://doi.org/10.1373/clinchem.2008.121285>
37. 2006) Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol. Res. 55, 667-674.
< , M., Krijt, J., Sulc, K., Necas, E. (https://doi.org/10.33549/physiolres.930841>
38. 2008) Increased hepcidin expression in colorectal carcinogenesis. World J. Gastroenterol. 14, 1339-1345.
< , D. G., Roberts, K., Brookes, M. J., Joy, H., Martin, A., Ismail, T., Spychal, R., Iqbal, T., Tselepis, C. (https://doi.org/10.3748/wjg.14.1339>
39. 2002) Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100, 3776-3781.
< , D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., Andrews, N. C. (https://doi.org/10.1182/blood-2002-04-1260>
40. 2005) Anemia of chronic disease. N. Engl. J. Med. 352, 1011-1023.
< , G., Goodnough, L. T. (https://doi.org/10.1056/NEJMra041809>
41. 2009) Iron metabolism in the anemia of chronic disease. Biochim. Biophys. Acta 1790, 682-693.
< , G. (https://doi.org/10.1016/j.bbagen.2008.08.006>
42. 2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108, 3204-3209.
< , D. M., Andrews, N. C. (https://doi.org/10.1182/blood-2006-06-027631>
43. 2009) Molecular mechanisms of normal iron homeostasis. Hematology Am. Soc. Hematol. Educ. Program, 207-214.
< , A. S., Enns, C. A. (https://doi.org/10.1182/asheducation-2009.1.207>
44. 2011) The swinging pendulum of the anemia of cancer: erythropoietin trumps hepcidin. J. Clin. Oncol. 29, e42.
< , S. (https://doi.org/10.1200/JCO.2010.32.2768>